Skip to main content
. Author manuscript; available in PMC: 2021 Dec 23.
Published in final edited form as: Endocr Relat Cancer. 2021 Nov 24;29(1):R17–R32. doi: 10.1530/ERC-21-0083

Figure 2.

Figure 2.

Muc4 mediates CTC survival in circulation. Muc4-positive CTCs form pro-survival cell aggregates with blood-borne cells during vascular transit, enabling them to more efficiently seed metastatic lesions at distant organs. On the other hand, Muc4-negative CTCs fail to survive the harsh conditions of transit, succumbing to shear forces and undergoing anoikis. These cells are unable to form CTC-blood cell aggregates, impairing their ability to successfully colonize metastatic lesions (Rowson-Hodel et al., 2018).